NCT03266653 EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection Status RECRUITING Phase PHASE2
NCT03266640 Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) Status RECRUITING Phase PHASE2
NCT03266627 Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection Status RECRUITING Phase PHASE2
NCT03261089 Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst Status RECRUITING Phase N/A
NCT03259360 A Facebook Intervention for Young Sexual and Gender Minority Smokers Status COMPLETED Phase NA
NCT03256539 Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease Status TERMINATED Phase NA
NCT03252145 Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device Status COMPLETED Phase NA
NCT03248570 Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects Status COMPLETED Phase PHASE2
NCT03243058 Low-dose IL-2 in Established T1D - The "PROREG" Study Status WITHDRAWN Phase PHASE1/PHASE2
NCT03232892 Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03228823 Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS) Status UNKNOWN Phase PHASE4
NCT03217058 Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care Status COMPLETED Phase NA
NCT03213613 Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents Status COMPLETED Phase NA